The global weight loss and obesity management market is set to experience remarkable expansion in the coming decade, with new projections indicating an increase from an estimated USD 14,511 million in 2024 to an impressive valuation of USD 48,396 million by 2034. This substantial growth reflects a robust compound annual growth rate (CAGR) of 12.8%, highlighting the dynamic evolution of the sector.
This anticipated growth is attributed to several key factors, including a significant shift in consumer attitudes towards health and wellness, advancements in treatment options, and the rising prevalence of obesity worldwide. As the market evolves, innovative solutions and comprehensive weight management programs are expected to drive this upward trajectory.
Key Factors Driving Market Growth:
- Rising Obesity Rates: The increasing global obesity rates are fueling demand for effective weight loss solutions. More individuals are proactively seeking to manage their weight, leading to a surge in the adoption of various obesity management programs.
- Technological Advancements: Innovations in technology, such as digital health solutions and advanced medical devices, are enhancing the effectiveness of weight loss treatments. These advancements are expected to play a pivotal role in driving market growth.
- Growing Awareness: Heightened awareness of the health risks associated with obesity is prompting individuals to invest in weight loss and obesity management solutions. This increasing consciousness is significantly contributing to market expansion.
- Government Initiatives: Supportive government policies and initiatives aimed at combating obesity are likely to create a favorable environment for market growth. Programs promoting healthy lifestyles and preventive measures are expected to further bolster the industry.
As the global weight loss and obesity management market continues to evolve, it is well-positioned for sustained growth. Rising obesity rates, technological innovations, increased awareness, and supportive government measures combine to create an expansive landscape of opportunities for industry stakeholders and investors.
Key Market Insights
- CAGR and Market Valuation: The global weight loss and obesity management market is projected to register a CAGR of 12.8% and achieve a valuation of USD 48,396 million by 2034.
- Dominant Segments: The drugs segment is expected to dominate the market, holding a 48.60% share in 2024. Additionally, the institution sales segment is anticipated to drive significant growth, capturing a 75.70% market share in 2024.
Market Dynamics and Competitive Landscape:
The market is characterized by intense competition, with numerous players offering a wide range of products and services, including weight loss programs, supplements, meal replacements, and fitness equipment. In addition to established companies, the market has seen the emergence of start-ups and niche players introducing innovative solutions to meet the growing demand for weight loss and obesity management.
Get the Latest on Weight Loss and Obesity Management: Our Full Report Highlights Key Trends and Insights!
Recent Developments
- Amgen Inc. (2021): Amgen disclosed the findings of a Phase 1 clinical trial involving AMG 133, a bispecific molecule designed as a GIPR antagonist and GLP-1 receptor agonist. The study focused on non-diabetic obese individuals and evaluated the molecule’s safety, tolerability, and pharmacokinetic and pharmacodynamic properties.
- Novo Nordisk (2021): Novo Nordisk developed semaglutide, a weight-loss drug that has demonstrated the ability to enhance the physical function and overall well-being of obese individuals.
Key Market Players
Prominent players in the global weight loss and obesity management market include:
- Atkins Nutritionals, Inc.
- Ethicon US, LLC
- Herbalife Ltd.
- Nutrisystem, Inc.
- Weight Watchers International, Inc.
- Jenny Craig, Inc.
- Apollo Endosurgery, Inc.
- Brunswick Corporation
- Covidien plc
Market Segmentation
- By Product Type: Devices (Liposuction Devices, Bariatric Stapling Devices, Gastric Bands, etc.), Drugs (GLP-1 Receptor Agonists, Lipase Inhibitors, etc.)
- By Distribution Channel: Institutional Sales (Hospitals, Weight Loss Clinics), Retail Sales (Retail Pharmacies, Online Sales)
- By Region: North America, Latin America, East Asia, South Asia, Europe, Oceania, Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube